|
Volumn 301, Issue 5632, 2003, Pages 487-492
|
Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD VESSELS;
CELLS;
MEDICINE;
MUSCLE;
STEM CELLS;
CYTOLOGY;
ALPHA SARCOGLYCAN;
LENTIVIRUS VECTOR;
SARCOGLYCAN;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
MICROBIOLOGY;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL ISOLATION;
CONTROLLED STUDY;
GENE TRANSFER;
LIMB GIRDLE MUSCULAR DYSTROPHY;
MESOANGIOBLAST;
MOUSE;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
STEM CELL;
TRANSGENIC MOUSE;
ANIMALS;
BLOOD VESSELS;
CELL DIFFERENTIATION;
CELL LINE;
CELL MOVEMENT;
CYTOSKELETAL PROTEINS;
DYSTROPHIN;
ENDOTHELIUM, VASCULAR;
FEMALE;
FEMORAL ARTERY;
GENETIC VECTORS;
LENTIVIRUS;
LOCOMOTION;
MALE;
MEMBRANE GLYCOPROTEINS;
MESODERM;
MICE;
MICE, KNOCKOUT;
MICE, TRANSGENIC;
MUSCLE CONTRACTION;
MUSCLE FIBERS;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, ANIMAL;
REGENERATION;
SARCOGLYCANS;
STEM CELL TRANSPLANTATION;
STEM CELLS;
TRANSFECTION;
ANIMALIA;
LENTIVIRUS;
MUS MUSCULUS;
|
EID: 0042344907
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1082254 Document Type: Article |
Times cited : (559)
|
References (38)
|